S

    Strata Critical Medical, Inc. (SRTA)

    Official site

    HEALTHCARE • NONE • NASDAQ

    $5.66
    -0.31 (-5.19%)

    Market Cap: $528.15M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(15/21)
    Avg Surprise
    -63.28%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.05 - $0.01
    4 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.02-166.7%
    60d ago$-0.01-77.3%
    30d ago$-0.01-77.3%
    7d ago$-0.01-77.3%
    Current$-0.01
    Revenue Consensus
    $73M
    Range$71M - $74M
    4 analysts
    Dec 31, 2026
    EPS Consensus$-0.03
    Range$-0.12 - $0.02
    4 analysts
    Revenue Consensus
    $87M
    Range$85M - $89M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.03---
    Sep 26EST
    		-$-0.01---
    Jun 26
    		$-0.01$-0.01+0.00%Beat+75.0%
    Mar 26
    		$0.04$-0.04+200.00%Beat+157.1%
    Dec 25
    		$-0.12$0.06-300.00%Miss+5.7%
    Sep 25
    		$-0.12$-0.02-500.00%Miss-1100.0%
    Jun 25
    		$-0.04$-0.05+20.00%Beat+33.3%
    Mar 25
    		$-0.07$-0.10+30.00%Beat+30.0%
    Dec 24
    		$-0.13$-0.12-10.60%Miss+1.7%
    Sep 24
    		$-0.01$-0.02+50.00%Beat+50.0%
    Jun 24
    		$-0.06$-0.06+0.00%Beat+33.3%
    Mar 24
    		$-0.10$-0.11+9.09%Beat+28.6%
    Dec 23
    		$-0.13$-0.12-7.92%Miss+41.1%
    Sep 23
    		$-0.02N/A+66.67%Beat+77.8%
    Jun 23
    		$-0.09$-0.10+10.00%Beat+18.2%
    Mar 23
    		$-0.14$-0.16+12.50%Beat+6.7%
    Dec 22
    		$-0.22$-0.20-10.00%Miss-69.2%
    Sep 22
    		$-0.09$-0.13+30.77%Beat+80.9%
    Jun 22
    		$-0.11$-0.19+42.11%Beat+66.8%
    Mar 22
    		$-0.15$-0.20+25.00%Beat+6.3%
    Sep 21
    		$-0.13$-0.14+7.14%Beat-1200.0%
    Jun 21
    		$-0.47$-0.47+0.00%Beat-234900.0%
    Mar 21
    		$-0.33$-0.03-1003.67%Miss-573.0%
    Dec 20
    		$-0.16N/AN/ABeat-328.6%
    Sep 20
    		$-0.01N/AN/ABeat-150.0%
    Jun 20
    		$-0.00N/AN/ABeat-
    Mar 20
    		$0.07N/AN/ABeat-
    Dec 19
    		$0.07N/AN/ABeat-
    Sep 19
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-26.95EV/EBITDA-9.95x
    Price/FCF-11.17xFCF Yield-8.96%
    Profitability
    Profit Margin15.70%Operating Margin-6.32%
    ROE-9.22%ROIC-5.95%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.64xQuick Ratio2.64x
    Trading Statistics
    Beta2.25Avg Volume1.06M
    52-Week High$6.5052-Week Low$3.85

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.99
    SMA 20$5.92
    SMA 50$5.51
    SMA 200$5.08
    EMA 10$5.95
    EMA 20$5.86
    EMA 50$5.64
    EMA 200$5.22

    MACD

    Line: 0.14Signal: 0.17Hist: -0.03

    ADX

    ADX: 26.6+DI: 19.7-DI: 21.8

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down8.0
    PSAR$6.32

    Bollinger Bands

    Upper Band$6.30
    Lower Band$5.54
    %B Position1280%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    46.8

    Momentum Oscillators

    Stoch %K41.7
    Stoch %D62.9
    Williams %R-96.4
    ROC (10d)-4.1%
    Momentum-0.24
    CCI (20d)-80.9
    MFI (14d)50.7

    Volatility Measures

    ATR (14d)$0.26(4.6%)
    StdDev (20d)0.19
    Hist Vol49.8%(High)

    Volume Flow

    VWAP$5.75
    OBV2.4M
    AD Line-7.8M
    CMF (20d)0.067

    Volume Metrics

    Avg Vol (20d)1.0M
    Vol Ratio0.9x
    VWMA (20d)$5.89

    Pivot Points

    R3$6.38
    R2$6.27
    R1$6.12
    Pivot Point$6.00
    S1$5.85
    S2$5.74
    S3$5.59

    Advanced Oscillators

    TSI14.43
    Ultimate Osc44.0
    KST133.45

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$72.51M$67.38M$66.79M$49.30M$70.80M$54.31M$54.36M$74.88M$67.94M$51.51M$47.48M$71.44M
    Cost of Revenue$57.29M$53.27M$55.12M$37.68M$53.06M$42.33M$41.77M$55.04M$51.59M$41.38M$38.47M$55.86M
    Gross Profit$15.21M$14.12M$11.67M$11.61M$17.74M$11.98M$12.59M$19.84M$16.35M$10.14M$9.01M$15.58M
    Operating Expenses$20.62M$17.09M$18.07M$17.24M$22.69M$19.56M$20.96M$23.37M$28.50M$20.01M$44.64M$23.03M
    R&D$1.01M$1.12M$1.70M$453,000$915,000$812,000$743,000$800,000$971,000$670,000$988,000$1.08M
    SG&A$8.82M$15.61M$16.82M$16.30M$20.14M$17.31M$18.95M$20.41M$25.14M$17.21M$41.24M$19.27M
    Operating Income$-5,408,000$-2,974,000$-6,405,000$-5,622,000$-4,954,000$-7,583,000$-8,372,000$-3,537,000$-12,149,000$-9,868,000$-35,633,000$-7,448,000
    Interest Income$331,000$473,000$638,000$1.13M$1.16M$1.32M$1.59M$1.76M$1.79M$0$0$0
    Interest Expense$5.11M$0$0$4.04M$0$0$1.53M$0$0$0$0$0
    Income Before Tax$-10,516,000$2.40M$-5,388,000$-9,657,000$-3,722,000$-3,510,000$-9,898,000$-2,072,000$-11,274,000$-4,318,000$-34,964,000$418,000
    Income Tax Expense$0$248,000$3.44M$-64,862,000$21,000$-17,000$-105,000$-118,000$52,000$-84,000$-1,023,000$129,000
    Net Income$-10,516,000$2.15M$-8,833,000$57.42M$-3,743,000$-3,493,000$-9,793,000$-1,954,000$-11,326,000$-4,234,000$-33,941,000$289,000
    EBITDA$-2,001,000$1.16M$-558,000$-7,953,000$-1,946,000$-1,813,000$-8,368,000$-793,000$-9,715,000$-2,724,000$-33,158,000$2.26M
    EBIT$-10,516,000$-1,905,000$-3,566,000$-9,657,000$-3,722,000$-3,510,000$-9,898,000$-2,072,000$-11,274,000$-4,318,000$-34,964,000$418,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SRTA

    News

    Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?

    Shares of Strata Critical Medical, Inc. (SRTA) have gained 23.8% recently, closing at $6.24. Wall Street analysts predict a potential upside of 47.3%, with a mean target of $9.19, despite some skepticism about the reliability of price targets. The positive outlook is further supported by strong agreement among analysts on the company's earnings prospects and a Zacks Rank #2 (Buy).

    Yahoo Finance•8/24/26•
    Bullish

    Strata critical medical director Reginald Love disposes of $29,273 in stock

    Reginald Love, a director at Strata Critical Medical, Inc. (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for $29,273 on August 10, 2026. Following the sale, Love directly holds 146,481 shares. The company's stock has shown strong momentum, with a 37.6% gain over the past year, despite being considered overvalued by InvestingPro analysis.

    Investing.com South Africa•8/14/26•
    Somewhat-Bearish

    Strata critical medical director Reginald Love disposes of $29,273 in stock

    Reginald Love, a director at Strata Critical Medical (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for a total of $29,273 on August 10, 2026. Following this transaction, Love still directly holds 146,481 shares. The company's stock has seen significant gains recently, but InvestingPro analysis suggests it may be overvalued despite a "GOOD" financial health score.

    Investing.com•8/14/26•
    Somewhat-Bearish

    Strata critical medical director Reginald Love disposes of $29,273 in stock

    Reginald Love, a director at Strata Critical Medical, sold 5,091 shares of the company's Class A common stock for $29,273 on August 10, 2026. Following the transaction, Love directly holds 146,481 shares. This sale occurred as SRTA shares have shown strong performance, though InvestingPro analysis suggests the stock may be overvalued.

    Investing.com•8/14/26•
    Neutral

    Strata Critical Medical (SRTA) director Reginald Love sells 5,091 shares at $5.75

    Strata Critical Medical, Inc. director Reginald Love sold 5,091 shares of Class A common stock at $5.75 per share on August 10, 2026. Following this transaction, his direct holdings in the company amount to 146,481 shares. The sale was reported in an open market or private transaction.

    Stock Titan•8/13/26•
    Somewhat-Bearish

    Frequently Asked Questions About SRTA

    Does SRTA pay dividends?
    Strata Critical Medical, Inc. (SRTA) does not currently pay a regular dividend.
    What is SRTA's market cap?
    Strata Critical Medical, Inc. (SRTA) has a market capitalization of $528.15M with a current stock price of $5.66.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In